InnovAge
INNV
$6.74
Share price
-0.74%
Change (1 day)
56.74%
Change (1 year)
Categories
InnovAge (INNV) - Total liabilities
Total liabilities on the balance sheet as of March 2023 : $0.24 B
According to InnovAge's latest financial reports the company's total liabilities are $0.24 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
InnovAge - Total liabilities on balance sheet (from 2020 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-06-30 | $0.20 B | 16.15% |
| 2021-06-30 | $0.17 B | -42.43% |
| 2020-06-30 | $0.30 B | 7.13% |
| 2019-06-30 | $0.28 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Merck MRK | $60.89 B | 24,879.49% | 🇺🇸 USA |
 Cocrystal Pharma
COCP | $1.59 M | -99.34% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $7.3 M | -97.00% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $3.98 B | 1,535.92% | 🇮🇪 Ireland |